Filing Details
- Accession Number:
- 0001209191-14-032426
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-08 21:25:45
- Reporting Period:
- 2014-05-07
- Filing Date:
- 2014-05-08
- Accepted Time:
- 2014-05-08 21:25:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178253 | Scynexis Inc | SCYX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604072 | Ii Capital Ventech | 47 Avenue De L?Opera Paris Cedex 07 I0 75002 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-07 | 14,005 | $0.20 | 14,005 | No | 4 | X | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 14,005 | $0.20 | 28,010 | No | 4 | X | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 43,704 | $0.20 | 71,714 | No | 4 | X | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 30,930 | $0.00 | 102,644 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 96,294 | $0.00 | 198,938 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 39,685 | $0.00 | 238,623 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 147,588 | $0.00 | 386,211 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-05-07 | 28,000 | $10.00 | 414,211 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrant (right to buy) | Disposition | 2014-05-07 | 14,005 | $0.00 | 14,005 | $0.20 |
Common Stock | Common Stock Warrant (right to buy) | Disposition | 2014-05-07 | 14,005 | $0.00 | 14,005 | $0.20 |
Common Stock | Common Stock Warrant (right to buy) | Disposition | 2014-05-07 | 43,704 | $0.00 | 43,704 | $0.20 |
Common Stock | Series B Preferred Stock | Disposition | 2014-05-07 | 109,879 | $0.00 | 30,930 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2014-05-07 | 340,509 | $0.00 | 96,294 | $0.00 |
Common Stock | Series D-1 Preferred Stock | Disposition | 2014-05-07 | 809,584 | $0.00 | 39,685 | $0.00 |
Common Stock | Series D-2 Preferred Stock | Disposition | 2014-05-07 | 3,010,807 | $0.00 | 147,588 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-12-07 | 2016-12-06 | No | 4 | X | Direct |
0 | 2012-05-15 | 2017-05-14 | No | 4 | X | Direct |
0 | 2013-12-11 | 2018-12-10 | No | 4 | X | Direct |
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
- Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
- Upon closing of the Issuer's initial public offering, each share of Series D-1 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.
- Upon closing of the Issuer's initial public offering, each share of Series D-2 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.